Easton Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Trellis BioscienceJan 2026 · $9M
BiotechRedwood City, US
Larry Kauvar(Chief Science Officer)Stefan Ryser(President and Chief Executive Officer)Geoff Dillon(Chief Business Officer)Elisabeth Whitney(Chief Operating Officer)Nora Mende(Chief Financial Officer)
PartnerJohn Friedman· quoted
Co-investorsAMR Action FundNew Science Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.